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ABSTRACT 
Purpose: 
Patient reported outcome (PRO) instruments are increasingly common in both clinical 
practice and research.  The data obtained from these instruments can be used to help inform 
decision-making and policy-making decisions.  The methodological approaches undertaken 
in developing PROs is not frequently reported.  Literature on the development of the 
descriptive systems for PROs is sparse in comparison to the assessment of the 
psychometric properties of such instruments.  The purpose of this study is to describe the 
methodological approach taken in identifying potential items for the Child Amblyopia 
Treatment Questionnaire (CAT-QoL); a paediatric disease-specific health related quality of 
life instrument for amblyopia designed for children aged 4 to 7 years.   
 
Methods 
Semi-structured interviews were undertaken with 59 children (age 3 yrs 9 months – 9 years 
11 months; average 6 years 3 months) with amblyopia.  Interview transcripts were analysed 
to identify potential items to be included in the descriptive system.   
 
Results: 
Eleven potential items were identified for inclusion in the Children’s Amblyopia Treatment 
Questionnaire (CAT-QoL) instrument.   
 
Conclusions: 
Children are able to identify their thoughts and opinions of their own health; and to describe 
what impact their amblyopia treatment has had upon their daily lives.  They are able to 
understand and articulate what it is they feel and have experienced because of their eye 
condition.  Items for the draft descriptive system for a paediatric self-reported amblyopia 
HRQoL have been identified. 
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The health related quality of life (HRQOL) implications of amblyopia are recognised1-12 
however, the way in which these have been described are largely via parent (or proxy) 
reporting2-4;6;8;13 and the instruments used to measure the HRQOL impact have been derived 
from clinician expert opinion.2-4;6;8;13;14  Recent Food and Drug Administration (FDA) guidance 
on patient reported outcome measures (PROs) state that the purpose of a PRO instrument 
is “to capture the patients experience, an instrument will not be a credible measure without 
evidence of its usefulness from the target population of patients”.15  They “discourage proxy-
reported outcome measures” for the paediatric population.15  Existing HRQOL instruments 
for amblyopia do not meet these recommendations.   
 
The overall purpose of this study was to develop a paediatric disease-specific HRQOL 
questionnaire for amblyopia that could be used in research or routine clinical practice.  The 
study comprises of a number of stages; a systematic literature review16; focus group 
sessions and analysis17; development of the descriptive system; and assessment of the 
psychometric properties of the questionnaire.  The literature review identified HRQoL 
implications of amblyopia and/or its treatment to inform a topic guide used for focus group 
sessions undertaken with clinicians.16  Focus group sessions were conducted to identify any 
additional HRQoL implications of amblyopia and/or its treatment not previously identified in 
the literature review.17   This paper reports upon the identification of potential items for 
inclusion in the Child Amblyopia Treatment Questionnaire (CAT-QOL).   
 
 
METHODS  
Interview Procedure  
The study was approved by the NHS Research Ethics Committee (REC Ref: 07/Q1201/5), 
and followed the tenets of the Declaration of Helsinki.  Semi-structured interviews were 
conducted with children attending Eye Clinics in Sheffield, United Kingdom (UK).  The 
inclusion criteria were that the child was aged over 4 years, and either had, or previously 
had, a clinical diagnosis of amblyopia.  Potential participants were identified following their 
scheduled consultation with the clinician.   
 
A topic guide was used for the interviews.  The topic guide contained themes to be 
discussed with the children, and not specific questions.  The aim was to use the child’s 
responses to develop the instrument.  If specific questions were to be used to interview the 
children, adults would have developed such questions (via clinicians’ input and informed by 
the literature reviews).  This would be imposing adult perspectives on a child’s response; 
and would go against the purpose of interviewing children to develop an instrument for 
children, by children.  Therefore, the interviews were only guided by the themes detailed in 
the topic guide.  The aim of the interviews was to identify how amblyopia and/or its treatment 
affect children’s lives, from the child’s perspective.  Children were encouraged to talk about 
their amblyopia treatment via open-ended questions.  Such as “tell me about your patch” and 
“what does your patch feel like”?  The child’s responses were probed to try to identify what 
aspects of the treatment impacted upon their daily lives.  Each interview was recorded, 
allowing the researcher to devote their full attention on the interview.18 
 
Qualitative analysis 
The interviews were transcribed verbatim and imported into QSR NVivo 8©, (QSR 
International, Doncaster, Australia).  The analysis was guided by the research question; 
“how does amblyopia and/or its treatment affect children’s lives?”  The aim of the analysis 
was to identify possible items (questions) to be included in the instrument.  Thematic content 
analysis (where themes are identified in which both the content and context of documents 
are analysed18) was undertaken using Framework.  Framework follows the principles of 
classifying and organizing data according to key themes, concepts and emergent 
categories.18  Each transcript was reviewed several times in order to become familiar with 
the data.   Key phrases, sentences and words, and emergent themes were identified.  
Transcripts were then re-examined and coded according to the identified themes.  Care was 
taken to keep the terminology and phrasing used by the children.  Once the transcripts were 
coded into themes, the data was organised into items for the draft instrument.  Lewis and 
Ritchie state that within qualitative research, internal validity issues such as sample 
coverage; sample of the phenomena; labelling; interpretation; and display of the data should 
all be considered.19  In doing so, the validity and subsequent generalisability of the data adds 
credibility to the research findings.  Following analysis of the interview data, three 
experienced and independent qualitative researchers validated the analysis approach taken.  
This involved an independent assessment of the analysis approach adopted, and also an 
assessment of the accuracy of the approach itself.  In the first instance, the conceptual 
Framework was reviewed.  Then samples of the transcripts were checked for coding 
consistency.   
 
 
RESULTS 
In total 59 children were interviewed, although it should be noted that not all of the interviews 
resulted in data that could be used for analysis.  Some of the interviews were terminated as 
the child was unresponsive (n=5).  Only seven interviews were conducted with the child 
alone, the majority of children were interviewed with their parent/guardian present.  The vast 
majority of participants were white (which was representative of the clinic population).   Table 
1 shows a summary of the characteristics of the study population.  Postcode data of each 
participant was used to categorize participants into socio-demographic classes.  This was 
calculated using GeoConvert20 to obtain a Lower Super Output Areas (LSOAs) ranking.  
There are over 32,000 LSOAs in England.  The LSOA ranked 1, by the Index of Multiple 
Deprivation (IMD) 2007, is the most deprived; and that ranked 32,842 is the least deprived.20  
 
A balanced demographic sample was achieved in relation to age, social class and amblyopia 
treatment modality (Tables 1 and 2).  The mean logMAR interocular difference in visual 
acuity (VA) (difference between VA in the dominant eye and VA in the amblyopic eye) was 
0.21; with a range of 0.725 and 0.0 log units (median 0.15 log units).  Participants were rated 
in terms of their amblyopia severity at both the start of treatment, and at the time of the pilot.  
This grading system adopted was that of the PEDIG model of amblyopia classification.21-28  
Mild amblyopia was categorised as 0 ≥ 0.3 logMAR; moderate amblyopia 0.31 ≥ 0.60 
logMAR; and severe amblyopia > 0.61 logMAR.  Co-morbidities as documented in the 
hospital records were noted.  The majority of participants were in good general health.  
Some of the participants (n=15) did have recorded co-morbidities.   These are listed. 
 
1. asthma and glue ear 
2. speech problems 
3. mild joint hypermobility 
4. otitis media 
5. Speech therapy 
6. juvenile arthritis and Still’s disease 
7. Coeliac disease, anaemia and failure to thrive 
8. chronic lung disease and conductive hearing loss 
9. mild eczema  
10. constipation 
11. Attention Deficit Hyperactivity Disorder (ADHD) and Asperger’s syndrome;  
12. history of prematurity, and delayed speech 
13. fourth nerve palsy, rhabdomyosarcoma of bladder and prostrate; 
14. Auditory language disorder and seizures 
15. Familial syndrome, facial dysmorphism, short stature, and restricted joint movement 
 
It is possible that other co-morbidities did exist in the study population, but that these were 
not severe enough to warrant hospital treatments and investigations.  Of the 59 children 
interviewed, all were on some form of treatment (either glasses; patch; drops; or a 
combination of these).  This is shown in Table 2. 
 
The majority of the children coped well with the interviews.  However, a number of interviews 
did need to be terminated, either at the request of the child, or if the child was unresponsive.  
Interviews varied in length from 1min 25secs to 15mins 34secs, with an average interview 
length of 6min 15secs.  Recruitment continued until data saturation was reached; and the 
number of interviews conducted exceeded this point.  Confidence that data saturation was 
achieved was high, as all interviews were conducted by one researcher.   
 
Item identification for possible inclusion in the CAT-QoL instrument 
Qualitative analysis of the interview data identified eleven possible items to be included in 
the draft questionnaire.  A conceptual Framework was derived purely from the qualitative 
data; this was not informed by existing literature before the qualitative data was collected.  
The aim was to analyse the data with an aim to identify possible items for the draft 
questionnaire, using a “bottom up” methodological approach.29  
 
1. Physical sensation of the treatment (e.g. feeling of the patch/glasses on the face, or the 
feeling of the drops being instilled) 
The children noted that some of the sensation of some of the treatments for amblyopia 
affected their HRQoL.  These stemmed from the physical sensations experienced by having 
something on their face (either a patch or glasses).  For example, “a bit tickly” (patch); “it just 
itches a bit near the eye….” (patch); “it tickles” (patch); “it feels a bit rough” (patch); “well it’s 
a bit hard to blink sometimes, because your eyes can get caught on the sticky bit” (patch); 
“rubbing on my ear...” (glasses).  Other children spoke about the feelings of having the drops 
(atropine) instilled (“it makes my tears; some tears come down”). 
 
2. Pain of treatment (hurt) 
Some children reported that treatment for amblyopia was painful or uncomfortable.  This was 
often associated with the wearing of a patch, and more specifically removing the patch at the 
end of the treatment period.  For example, “It kept rubbing on my face and it hurt….” (patch); 
“when I take it off it hurts” (patch); “it feeled that when I took it off it hurted, and when I 
weared it, it tickled” (patch) ; “it hurts when I take it off” (patch); “they really burnt when they 
took it off cos it actually took some hair off my eyebrow!” (patch). 
 
Similarly, some children reported that when the drops (atropine) were instilled, these would 
often sting or make their eyes water.  For example, “Well it starts, stings and it wears off a 
bit”.  A number of children also reported that their glasses were uncomfortable (“Er, my nose 
starts rubbing on both sides”). 
 
3. Being able to play with other children 
Some children discussed how relationships with their friends were affected because of 
amblyopia treatment.   For example, “Sometimes like, sometimes when I’m playing a game 
and they say like we’re playing “High School Musical” or something like that, and people, you 
know you’re not supposed to wear glasses.  They just like say “oh you’ve got to take them 
glasses off and put them somewhere” and I say “no”, so I just go away and cry”; “Because I 
could see them far away.  But actually they were near me but that’s why I couldn’t play with 
them because I,.. because then I kept on going past them”; and “Cause, cause all the time 
that *** said I’m too thick to play, when I’m not”. 
 
4. How other children have treated them (like laughing or name-calling) 
Some children discussed bullying, such as name-calling and exclusion from 
games/friendships.  To some, this was raised as something they had directly experienced 
(“when *** calls me a geek” and “Specky four eyes” (due to wearing glasses); however, 
others mentioned that they were more worried or concerned about what their friends/peers 
would say if they undertook their amblyopia treatment (patching) at school.  For example, “I 
haven’t told them … It was a secret … Because they would just laugh at me” (having to wear 
a patch). 
 
5. Ability to undertake work at school 
This item originated from children’s responses/thoughts about how their condition, or more 
specifically their treatment, influenced upon their ability to function at school.  Some of the 
comments were positive in nature (“they’re better to see stuff”, glasses), although mainly it 
was difficulties in undertaking tasks that were highlighted.  For example, “I can’t see writing”; 
“the teacher writes on the board I can’t even see”; “at school when I am doing the work, 
because the eye was covered it was harder to do things”.  The children noted that the ability 
to read and write was affected to varying degrees (“I can’t write letters right straight”). 
 
6. Ability to undertake other tasks (like playing on the computer, colouring, playing games, 
watching TV) 
The children also noted that their amblyopia treatment also influenced their ability to 
undertake other tasks.  These were mainly hobbies and interests, such as watching 
television or playing on computer games.  For example, “I can’t play with the bricks”; “when I 
go on Xbox360 I always get killed”; “when I am playing on the Wii, I can’t concentrate very 
much”; “on the computer and stuff... It sort of blurred”.  Some children noted that when they 
were having their treatment they were unable to participate in particular tasks (“go 
swimming”; or “eating my dinner”).  Another noted that when they wore their patch walking 
around was more difficult (“when you try like, try to see, erm, like chairs and stuff.  You can’t 
see your way”). 
 
7. Feeling sad or unhappy 
Some children reported that their treatment made them feel happy (“happy ….. because it 
makes my eyes see much farer” (glasses), whereas others stated that having to wear their 
patch or have drops instilled made them feel unhappy or sad.  For example, “it makes me 
feel sad because I want to play on the computer now but I don’t want to wear my patch”; 
“sad, because I didn’t want to wear them at the start… because I didn’t know what they felt 
like” (patch); “sad… because it,... you don’t like it on your eye.  When you first like, ...  say 
you have to wear a patch, and you feel like you have to have the patch on , its fun and when 
you start wearing it it’s not fun”.  
 
8. Feeling cross 
Some children stated that having to wear their patch or have drops instilled made them feel 
angry or cross.  For example, “I just feel angry”; “I feel a bit cross”; “I get grumpy… because I 
hate… I hate putting the patch on”; “with the sticky patch I get angry”. 
 
9. Feeling worried 
Some children reported that their amblyopia treatment made them feel nervous or worried.  
In some cases this related to worry about pain or discomfort, for example having the drop 
being instilled (“a little bit nervous”).  Others were worried about what they would look like 
when they had the patch on.  For example, “I thought I might look silly at school”. 
 
10. Feeling frustrated 
Some children reported that they felt frustrated at times due to their amblyopia treatment.  
This was often reported in conjunction with the ability of undertaking daily tasks, or in 
affecting relationships with others.  (“on certain days that I’ve been a little bit frustrated at 
school,…  Well, maybe if they’ve kicked me out a game when it was, maybe if they’re not 
letting me in a game or something like that, or they’ve been nasty to me and said nasty 
words maybe, I get a bit frustrated then”). 
 
11. Feelings towards family members (like parents or siblings) 
This item originated from children’s responses/thoughts about how their condition and/or 
treatment affected their relationships with others.  To some this was relationships with 
parents and other family members (“She’s always laughing saying “oh you look funny and 
this….”).  Children described that they would argue with their parents about having to have 
their treatment.  Some went on to say that they would get cross with their parents.   
 
 
DISCUSSION 
The use of PROs is becoming increasingly common and it is important to know how these 
have been developed and validated.  The FDA encourages instrument developers to make 
their instruments and related development history available and accessible publically.15  
However, the literature on the development of the descriptive systems for PROs is sparse.  
This study describes the development of the descriptive system for the CAT-QoL instrument, 
prior to any further refinement of the instrument. 
 
Matza et al have identified a number of considerations to be made when designing a 
paediatric HRQoL instrument.30  The first is the age at which children can report their own 
HRQoL.  Children do seem to have the capacity to reliably report upon their health between 
the ages of 4-6 years.31-33  The findings of this study confirms this.  It was possible to 
interview young children in order to identify their thoughts and opinions of their own health; 
and to find out what impact amblyopia treatment has had upon their daily lives.  Children are 
able to understand and articulate what it is they feel and experience due to their eye 
condition.   
 
Children were able to discuss and explore how their amblyopia treatment impacted upon 
their daily lives.  The interview questions were intentionally “open-ended”, and every effort 
was made not to prompt participants.  That said, some issues were probed; an attempt was 
made to find out exactly how they felt or experienced problems as a result of their amblyopia 
and/or treatment.  It could be argued that this is a different complexity of task (cognitively 
speaking) compared to responding to questions on a self-complete questionnaire.   
 
 Analysis of the interview data identified potential items for inclusion in the CAT-QoL 
instrument.  A theoretical HRQoL framework, was not utilized for a number of reasons.  
Firstly, there is no universally agreed definition of the concept of “HRQoL”.  If a theoretical 
framework were to be applied, then the choice of definition (and therefore content of the 
framework itself) could be argued.  The definition of “paediatric HRQoL” is also far from 
agreed.  In a review of paediatric QoL instruments, Davis et al reported upon the range of 
definitions, theories, domains and items used in the conceptual framework of child HRQoL.34  
The use of a theoretical framework in this study was counterintuitive.  The overall aim of the 
research was to produce an instrument for children, by children, using a bottom-up 
methodological approach.   
 
The number of interviews conducted to develop descriptive systems for PRO instruments is 
not always reported.  In qualitative studies, the aim is not to achieve statistical significance 
but to capture views of a given population.  The number of interviews conducted in this study 
(n=59), is slightly lower than that carried out during the development phase of the generic 
Child Health Utility 9D (CHU9D) instrument (n=74).35  The length of the interviews short, but 
not dissimilar to those reported in the development of the CHU9D questionnaire.35  This is 
unsurprising, as in this study the children were only asked to consider one aspect of their 
health, as opposed to their general health.  The age group was younger, and therefore not 
as likely to describe things in as much depth compared to older children. 
 
The research is not without limitations: the main being that the majority of interviews were 
conducted with the parent/guardian present.  The information sheet given to 
parents/guardians detailing the study did state that the child would be interviewed alone; 
however, they could be present if they wished.  There are advantages and disadvantages to 
a child being interviewed alone.  Firstly, it could be perceived that the child would be free 
and comfortable to express their thoughts, without a risk of upsetting their parents.  
Interviewing a child alone can also be perceived as being quite confrontational.  It could be 
argued that the children did not feel able to speak freely about their feelings about treatment 
for fear of upsetting their parent/guardian.  There were times during interviews when the 
children would look to parents for reassurance; these were noted and taken into 
consideration during the analysis of the interview data.  Interviewing children alone can 
compromise the researcher when considering the possibility of divulging potentially sensitive 
information about treatment, bullying or family dynamics.  It is acknowledged that 
interviewing children in the presence of a parent/guardian may have changed the dynamic of 
the relationship between the child and the interviewer (and as such, may have altered the 
content of the interview itself).  This is an important consideration particularly when reflecting 
on the “bottom up” methodological approach adopted in this research.  The debate 
surrounding the appropriateness of this form of data collection in children is complex.  For 
the purpose of this study, all interviews were conducted in a manner to satisfy 
parent/guardian’s wishes.  The use of focus groups may have allowed discussion of ideas 
between participants; however, this approach was not taken due to the potential sensitive 
nature of some of the issues raised.   
 The interviews were conducted in the Eye Clinic.  There are notable advantages and 
disadvantages associated with this approach.  Firstly, the child is familiar with this 
environment.  They will have attended the clinic on a number of occasions prior to interview.  
A disadvantage of this approach is that some participants may have felt obligated to take 
part in the study.36   
 
Another disadvantage could be the perceived notion that the interview has some link or 
association with their treatment.  It is possible that the responses given by the child 
participants were not entirely honest or open.  It may be that they believed the interviewer to 
be a clinician, so that they could not say that they hated their patch for example, in case they 
were “told off”.  Every effort was made to ensure that the child participant was aware that we 
were interested in their thoughts and feelings; and that the interviewer was not a clinician; 
and that all the information they provided was confidential. 
 
It is acknowledged that the interviews were conducted in only one area of the UK, due to 
resource constraints.  Nonetheless, the sample of the child interview participants was 
balanced in relation to age, social class and treatment modality.  In qualitative methodology, 
the aim is not to achieve statistical representativeness, but to capture the experiences of a 
given population (interviewing until data saturation has been reached).18   This was achieved 
in this study.  However, it should be noted that there are low numbers of child participants 
from differing ethnic backgrounds.  Further research is needed to identify if there are any 
additional HRQoL issues for given ethnic groups. 
 
Items for the draft descriptive system for a paediatric self-reported amblyopia HRQoL have 
been identified.  A draft version of the CAT-QoL instrument has been developed using the 
methods outlined in this paper.  Further research is required to refine and assess the 
psychometric properties of the instrument. 
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Table 1   Characteristics of the study population (n=59) 
 Total 
Study Population 36 male; 23 female 
Ethnicity 
White   
Mixed (white and Asian)   
Asian – Pakistani   
Chinese   
Black (African)  
Other   
 
54 
1 
1 
1 
1 
1 
Socio-demographic group using LSOA scores (worst 
deprived – least deprived) 
0-6500  
6501-13,000 
13,001-19,500    
19,501-26,000 
26,001-32,500 
 
 
21 
7 
14 
12 
5 
Number of participants with co-morbidities present 15 
Interocular Visual Acuity (VA) difference in logMAR Mean  0.21 log units 
Median  0.15 log units 
Min 0.0 log units 
Max 0.725 log units 
Interocular difference at time of interview 
Mild 
Moderate 
Severe 
 
46 
9 
4 
Amblyopia level from “normal” at time of interview 
Mild  
Moderate  
Severe 
 
41 
11 
7 
Mild amblyopia 0 ≥ 0.3 logMAR;  
Moderate amblyopia 0.31 ≥ 0.60 logMAR;  
Severe amblyopia > 0.61 logMAR.   
Table 2 Summary sampling grid:  Age and treatment modality 
Age(years) Patch 
Now 
Patch 
Ever 
Drops 
Now 
Drops 
Ever 
Glasses 
Now 
3 (n=1) 1 1 0 0 0 
4 (n=6) 5 1 0 0 4 
5 (n=20) 16 5 3 4 18 
6 (n=14) 9 6 4 2 12 
7 (n=13) 7 9 2 2 13 
8 (n=4) 1 3 1 1 4 
9 (n=1) 0 1 0 1 1 
TOTAL (n=59) 39 26 10 10 52 
*Categories are not mutually exclusive 
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